| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 658 |
| 1 | ADALIMUMAB | 525 |
| 2 | PREDNISONE | 446 |
| 3 | DEXAMETHASONE | 400 |
| 4 | DEXAMETHASONE 1.5 MG | 400 |
| 5 | PREDNISOLONE | 332 |
| 6 | PREDNISOLONE ORAL | 332 |
| 7 | PREDNISOLONE ORAL SOLUTION | 332 |
| 8 | METHOTREXATE SODIUM | 280 |
| 9 | FLUOROURACIL | 266 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 6 | 0.0172 |
| 1 | SEVELAMER HYDROCHLORIDE | 7 | 0.0122 |
| 2 | SACCHAROMYCES CEREVISIAE | 10 | 0.0109 |
| 3 | PSYLLIUM HUSK | 14 | 0.0104 |
| 4 | LEVOLEUCOVORIN INJECTION | 30 | 0.0098 |
| 5 | NEOSTIGMINE METHYLSULFATE | 4 | 0.0093 |
| 6 | LEVOLEUCOVORIN | 33 | 0.0086 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 71 | 0.0085 |
| 8 | LANTHANUM CARBONATE | 43 | 0.0084 |
| 9 | LOXAPINE | 28 | 0.0070 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1371 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 685 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 659 |
| 3 | Platinum-based Drug [EPC] | 650 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 497 |
| 5 | Microtubule Inhibitor [EPC] | 366 |
| 6 | Proton Pump Inhibitor [EPC] | 363 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 338 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 309 |
| 9 | Benzodiazepine [EPC] | 284 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Non-Standardized Fungal Allergenic Extract [EPC] | 11 | 0.0051 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 30 | 0.0047 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 685 | 0.0037 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 178 | 0.0037 |
| 4 | Human Blood Coagulation Factor [EPC] | 3 | 0.0036 |
| 5 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 12 | 0.0033 |
| 6 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 5 | 0.0033 |
| 7 | 5-Lipoxygenase Inhibitor [EPC] | 2 | 0.0031 |
| 8 | Echinocandin Antifungal [EPC] | 22 | 0.0027 |
| 9 | Platinum-based Drug [EPC] | 650 | 0.0024 |